NIH-funded research R01 grant

How a hormone from fat cells affects obesity

Official title: Distinct functions of adipocyte-derived FGF21 in obesity

Funded at University of Washington · NIH-11043365 · Data updated 2026-11-12

This study is looking at how a hormone called FGF21, made by fat cells, affects weight and blood sugar levels in people with obesity, using animal models to find new ways to help with weight loss and improve metabolic health.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startMarch 1, 2024
Project endFebruary 28, 2029
Funding year2025
Award (this year)$485,375
NIH project number5R01DK135756-02
Project IDNIH-11043365 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals struggling with obesity or metabolic syndrome.

Less likely to help

Patients who are not overweight or do not have metabolic issues may not benefit from this research.

What this research studies

This research investigates the role of fibroblast growth factor 21 (FGF21), a hormone produced by fat cells, in the context of obesity. It aims to understand how this hormone influences body weight and glucose metabolism, particularly in individuals with obesity. The study will utilize animal models to explore the distinct functions of FGF21 derived from adipose tissue compared to that from the liver, focusing on its effects on energy balance and insulin sensitivity. By examining these mechanisms, the research seeks to identify potential new strategies for weight loss and metabolic health.

Why it matters

Potential benefit: If successful, this research could lead to novel treatments for obesity and related metabolic disorders.

How similar studies have gone: Previous research has shown promising results regarding the role of FGF21 in metabolism, but the specific focus on adipocyte-derived FGF21 is relatively novel.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Den Hartigh, Laura Jane — University of Washington
  • Study coordinator: Den Hartigh, Laura Jane

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.